Efficacy and safety of empagliflozin and metformin with sitagliptin and metformin during Ramadan: An observational study

被引：0
|
作者：
Ahmed, I. [1 ]
Raja, U. [2 ]
Wahab, U. [3 ]
Aamir, A. H. [4 ]
Ghaffar, T. [4 ]
Kumar, S. [5 ]
Raza, A. [6 ]
Masood, F. [7 ]
Asghar, A. [8 ]
Tejhmal, R. [9 ]
Randhawa, F. A. [10 ]
Sherin, A. [11 ]
机构：
[1] Lady Reading Hosp, Endocrinol, Peshawar, Pakistan
[2] Shifa Int Hosp, Diabet & Endocrinol, Islamabad, Pakistan
[3] Umar Diabet Fdn, Diabet, Islamabad, Pakistan
[4] Hayatabad Med Complex, Endocrinol, Peshawar, Pakistan
[5] Bolan Med Coll, Endocrinol, Quetta, Pakistan
[6] Shauqat Khanum Hosp, Endocrinol, Lahore, Pakistan
[7] AlKhaliq Hosp, Diabet, Multan, Pakistan
[8] Liaqat Natl Hosp, Endocrinol, Karachi, Pakistan
[9] Shifa Int Hosp, Endocrinol, Islamabad, Pakistan
[10] Mayo Hosp, Endocrinol, Lahore, Pakistan
[11] KMU Inst Med Sci, Med, Kohat, Pakistan
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2022年 / 186卷
关键词：
D O I：
10.1016/j.diabres.2022.109586
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
IDF21-0642
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Initial combination of metformin, sitagliptin, and empagliflozin in drug-naive patients with type 2 diabetes: Safety and metabolic effects
    Lim, Soo
    Sohn, Minji
    Shin, Yujin
    Ferrannini, Ele
    DIABETES OBESITY & METABOLISM, 2022, 24 (04): : 757 - 762
  • [22] Efficacy of Dapagliflozin plus Sitagliptin plus Metformin Versus Sitagliptin plus Metformin in T2DM Inadequately Controlled on Metformin Monotherapy: A Multicentric Randomized Trial
    Singh, Awadhesh Kumar
    Das, Ashok Kumar
    Murthy, L. Sreenivasa
    Ghosal, Samit
    Sahay, Rakesh
    Harikumar, K. V. S.
    Keshava, Ganesh Hosahithlu
    Agarwal, Mayur
    Vijayakumar, G.
    Kalra, Pramila
    Lodha, Piyush
    Das, Sambit
    Shaikh, Shehla
    Goswami, Soumik
    Ajish, T. P.
    Kumthekar, Prashant
    Upadhyay, Mihir
    Thamburaj, Anthuvan
    Mahule, Aushili
    Prasad, Ashish
    Pednekar, Abhijit
    ADVANCES IN THERAPY, 2025, 42 (02) : 801 - 812
  • [23] Efficacy and safety profile of sitagliptin, vildagliptin, and metformin in newly diagnosed type 2 diabetic subjects
    Elhini, Sahar Hossam
    Hussien, Amal K.
    Omran, Ahmed Abd Elsamie
    Elsayed, Asmaa A.
    Saeed, Haitham
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2021, 48 (12) : 1589 - 1602
  • [24] Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes
    Scott, R.
    Loeys, T.
    Davies, M. J.
    Engel, S. S.
    DIABETES OBESITY & METABOLISM, 2008, 10 (10): : 959 - 969
  • [25] Safety and Efficacy of Sitagliptin-Metformin in Fixed Combination for the Treatment of Type 2 Diabetes Mellitus
    Ballav, Chitrabhanu
    Gough, Stephen C. L.
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2013, 6 : 25 - 37
  • [26] Efficacy and safety of liraglutide versus sulphonylurea both in combination with metformin during Ramadan in subjects with type 2 diabetes (LIRA-Ramadan): a randomised trial
    Azar, S.
    Echtay, A.
    Bebakar, W. Wan
    Al Araj, S.
    Berrah, A.
    Omar, M.
    Mutha, A.
    Tornoe, K.
    Kaltoft, M.
    Shehadeh, N.
    DIABETOLOGIA, 2015, 58 : S82 - S83
  • [27] The safety of empagliflozin plus metformin for the treatment of type 2 diabetes
    Scheen, Andre J.
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (08) : 837 - 848
  • [28] To Compare the Efficacy of Dapagliflozin & Metformin Vs Sitagliptin & Metformin in Newly Diagnosed Type 2 Diabetic patients
    Abdullah, Faiq
    Sattar, Abdul
    Shaukat, Kamran
    Ahmad, Sarfraz
    Nawaz, Shahid
    Maryam, Bushra
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (01): : 85 - 86
  • [29] Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study
    Williams-Herman, Debora
    Johnson, Jeremy
    Teng, Rujun
    Luo, Edmund
    Davies, Michael J.
    Kaufman, Keith D.
    Goldstein, Barry J.
    Amatruda, John M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (03) : 569 - 583
  • [30] Safety and efficacy of metformin in a restricted formulary
    Swislocki, ALM
    Khuu, Q
    Liao, E
    Wu, E
    Beza, F
    Lopez, J
    Kwan, G
    Noth, RH
    AMERICAN JOURNAL OF MANAGED CARE, 1999, 5 (01): : 62 - 68
12345